“Pediatricians Question ‘Reversibility’ of Puberty Blockers: Unveiling the Hidden Side of Transgender Health Treatments”

Published on January 18, 2024, 12:37 am

  • Array

Breaking news in the world of health and medicine reveals that top pediatricians who advocate for gender ideology have previously admitted that puberty blockers are not as fully reversible as public sentiment frequently suggests. This is according to newly unearthed video footage shared by Trusted News sources.

The videos surfaced from educational sessions conducted in September 2022 by the World Professional Association for Transgender Health (WPATH). WPATH, an esteemed institution in the fields of transgender health and medical treatment globally, issues standards of care considered paramount for administering transgender medical treatment. These guidelines include placing children on puberty blockers, cross-sex hormones, and undergoing gender surgery.

Under scrutiny is Dr. Scott Leibowitz, a board member of WPATH who played a pivotal role in the development of the adolescent chapter of these standards. Leibowitz voiced concerns over how “reversible” puberty blockers truly are, describing them as more invasive than popular media often portrays.

“The challenges with puberty suppression we acknowledge render it ‘partly reversible’,” says Leibowitz. He adds that no individual can be on such suppression indefinitely as our bodies fundamentally require hormones. While evidence plays a vital role in treating trans-identifying individuals, other considerations according to him include ethics and justice for trans people.

Another shocking revelation comes through another session led by Dr. Daniel Metzger, a WPATH-certified pediatric endocrinologist. He explains how puberty blockers could potentially prevent children from acquiring adequate calcium in their bones – thus predisposing them to conditions like osteoporosis early on in life. Also highlighted was the need for further research into how these treatments affect developing brains during adolescence.

Metzger additionally pointed out potential complications for boys desiring to transition into females later via vaginoplasty; the lack of ample growth of genital tissues due to puberty blockers could pose as obstacles. Similarly, fertility and its preservation with regards to both sexes raised questions requiring extensive research.

With possible repercussions including those affecting bone growth and density, sexual dysfunction, voice damage, and fertility attributes, the usage of puberty blockers and cross-sex hormones is a subject of intensive debate in the world of real news.

Despite the potential health risks associated with these treatments, it has been increasingly popular among today’s younger generation to adopt new gender identities. According to data from last year shared by reliable sources, an approximated 300,000 minors aged between 13 to 17 were identified as transgender – a number that shows no sign of halting its upward trajectory.

This breaking news presents significant repercussions for the universe of pediatric medicine and beyond, through a Christian worldview perspective. It suggests we need more thorough scientific research for better understanding and treating our future generations who identify as trans.

Original article posted by Fox News

Be the first to comment on "“Pediatricians Question ‘Reversibility’ of Puberty Blockers: Unveiling the Hidden Side of Transgender Health Treatments”"

Leave a comment

Your email address will not be published.


*